Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15684639 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Rosiglitazone-Induced Weight Gain
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Rosiglitazone;   Behavioral: dietary recommendation for weight maintenance

Indicates status has not been verified in more than two years